CORPORATIONS PROFIT FROM YOUR DNA

A recent article in “Nature” reports that an international team of scientists edited the DNA in human embryos to fix a disease gene. Described as a “technical tour de force”, the procedure succeeded without introducing the harmful mutations that dogged previous attempts. DNA research has dramatically accelerated since the human genome was first sequenced in 2003. Is it moving too fast?